Pharmaceuticals drive J&J to better-than-expected quarterly profit

by NEIRG NEWS | Apr 16, 2019

(Reuters) – Johnson & Johnson on Tuesday reported a first-quarter profit that exceeded Wall Street expectations on higher sales of its prescription medicines, including a double-digit increase for its psoriasis treatment Stelara, even as the company faces fierce competition for some of its other important drugs.

Read the full article here.